References

Projections of global mortality and burden of disease from 2002 to 2030.

Mathers CD, Loncar D. PLoS Med, 2006, 3(11):e442.

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative
meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration.
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio et al. Lancet. 2010; 26;375:2215-
2222.

Diabetes Res Clin Pract. 2009 Nov;86(2):130-3. doi: 10.1016/j.diabres.2009.07.014. Epub 2009 Sep 19.
The incidence of type 2 diabetes mellitus in the Philippines: a 9-year cohort study.
Soria ML1, Sy RG, Vega BS, Ty-Willing T, Abenir-Gallardo A, Velandria F, Punzalan FE.

Good practices for pharmaceutical microbiology laboratories (2011)

WHO Technical Report Series, No. 961, Annex 2, 2011

Sefil, F., Ulutas, K. T., Dokuyucu, R., Sumbul, A. T., Yengil, E., Yagiz, A. E., ... Gokce, C. (2014). Investigation
of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus.
The Journal of International Medical Research, 42, 581588.

Twig, G., Afek, A., Shamiss, A., Derazne, E., Tzur, D., Gordon, B., & Tirosh, A. (2013). White blood cells
count and incidence of type 2 diabetes in young men. Diabetes Care, 36, 276282.

Vozarova, B., Weyer, C., Lindsay, R. S., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002). High white
blood cell count is associated with a worsening of insulin sensitivity and predicts the development of
type 2 diabetes. Diabetes, 51, 455461.

http://www.nhs.uk/Conditions/Diabetes-type2/Pages/Introduction.aspx

http://www.who.int/diabetes/publications/en/screening_mnc03.pdf

Hoefner DM. The ruthless malady: Metabolic Syndrome. Medical Laboratory Observer 2003;35:(10):12-
23.

Rea R, Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?
Diabetes Obes Metab. 2004;6:163-170.

Gabriely I, Ma XH, Yang XM, Atzmon G, et al. Removal of visceral fat prevents insulin resistance and
glucose intolerance of aging: an adipokine-mediated process? Diabetes. 2002;51(10):2951-2958.

Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and
type 2 diabetes. Exp Clin Endocrinol Diabetes. 2003;111(3):121-124.

Boden G, Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent
diabetes. J Clin Invest. 1995;96(3):1261-1268.
Eriksson J, Franssila-Kallunki A, Ekstrand AV, Saloranta C, Widen E, Schalin C, et al. Early metabolic defects
in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321 : 337-
43.